Vistin Pharma ASA: Notice of Annual General Meeting 22 May 2025

29 Apr 2025 11:30 CEST

Oslo, Norway, 29 April 2025

Vistin Pharma ASA (OSE: VISTN), please find attached the call for the Annual
General Meeting in Vistin Pharma, to be held on 22 May 2025 at 13:00 CEST.

A physical Annual General Meeting will not be held. Instead, shareholders should
authorize the Chairman of the Board. It is possible to give proxy with and
without voting instructions. By using a proxy with voting instructions, the
shareholders will vote on the specific issues without personal attendance. For
further information on the use of proxy, see general information at the bottom
of the notice and enclosed proxy forms.

The recommendation from the Election Committee is attached the notice and
available on the Company's website. The formal call will be sent to all
shareholders registered in the Norwegian Central Security Depository (VPS) and
are also attached to this announcement.

For further information, please contact:

Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com (mailto:alexander.karlsen@vistin.com)

This information is subject to the disclosure requirements pursuant to
section 5-12 of the Norwegian Securities Trading Act.

More information:
Access the news on Oslo Bors NewsWeb site

644706_2025 03 13 Vistin Pharma election committee proposal.pdf
644706_Remuneration policy for salary and other remuration for executive management and board members_Vistin Pharma ASA.pdf
644706_Call for annual general meeting 22 May 2025 Vistin Pharma ASA.pdf
644706_Annual Report 2024 Vistin Pharma ASA.pdf
644706_Vistinpharmaasa-2024-12-31-0-en.zip